International Collaboration in Real-World Evidence Generation for Direct Acting Oral Anti-Coagulants
Clin Pharmacol Ther
.
2021 Feb;109(2):299-301.
doi: 10.1002/cpt.1999.
Epub 2020 Aug 28.
Authors
Peter Arlett
1
2
,
Xavier Kurz
1
,
Katherine Soltys
3
,
Michael D Blum
4
Affiliations
1
Data Analytics and Methods Task Force, European Medicines Agency, Amsterdam, The Netherlands.
2
Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
3
Health Products and Food Branch, Marketed Health Products Directorate, Health Canada, Ottawa, Ontario, Canada.
4
Office of Surveillance and Epidemiology, Centre for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
PMID:
32857416
PMCID:
PMC7461174
DOI:
10.1002/cpt.1999
No abstract available
Publication types
Observational Study
MeSH terms
Administration, Oral
Anticoagulants / therapeutic use*
Canada
Europe
Humans
Intersectoral Collaboration
Longitudinal Studies
United States
United States Food and Drug Administration
Substances
Anticoagulants